Biotech

All Articles

AstraZeneca pays CSPC $100M for preclinical heart problem medication

.AstraZeneca has paid CSPC Drug Group $100 thousand for a preclinical heart disease medication. The ...

Zephyrm looks for Hong Kong IPO to money period 3 cell treatment trials

.Zephyrm Bioscience is gusting towards the Hong Kong stock exchange, submitting (PDF) for an IPO to ...

Frazier Lifestyle Sciences gathers $630M for small, mid-cap biotechs

.Frazier Daily life Sciences has actually sourced an additionally $630 thousand for its own fund foc...

GigaGen amasses around $135M BARDA dollars to beat botox

.Antitoxin aficionado GigaGen, a subsidiary of Spanish biopharma Grifols, is ramping up its own spec...

GPCR firm Septerna declare IPO on durability of preclinical data

.Septerna is about to find out just how a biotech without "any relevant scientific information" fare...

Kurma shuts initially $154M haul for most significant biotech fund yet

.International VC agency Kurma Partners has actually unveiled its most current biotech fund, with 14...

Prothena markets one officer while one more keeps-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our summary of considerable leadership hirings, shooting...

Editas exploit Tip Cas9 licensing civil liberties for $57M

.Versus the background of a Cas9 license war that rejects to perish, Editas Medication is actually m...

Ultragenyx changes genetics treatment application to dial up effectiveness

.A minority of patients taking Ultragenyx Drug's Wilson health condition gene treatment UX701 have g...

Biopharma layoff cost maintains in Q3: Tough Biotech analysis

.As summertime heat relies on cool down winds, hopes that this year would carry widespread sector co...